News & Updates

What is the most preferred first-line agent for paediatric alopecia areata?
What is the most preferred first-line agent for paediatric alopecia areata?
25 May 2022 byStephen Padilla

In the treatment of paediatric alopecia areata (AA), an autoimmune, nonscarring hair loss disorder with a variable disease course and significant psychosocial impact, the most preferred first-line agent is topical corticosteroids, followed by contact immunotherapy, according to a study.

What is the most preferred first-line agent for paediatric alopecia areata?
25 May 2022
Prenatal Zika delays neurodevelopment in kids
Prenatal Zika delays neurodevelopment in kids
25 May 2022

Infants of mothers with Zika virus infection suffer from various neurodevelopmental sequelae during childhood, particularly in terms of language, a new study reveals.

Prenatal Zika delays neurodevelopment in kids
25 May 2022
Hypothyroidism, lower FT4 levels tied to greater T2D risk
Hypothyroidism, lower FT4 levels tied to greater T2D risk
24 May 2022

People with hypothyroidism and lower free thyroxine (FT4) levels in the reference range have a higher risk of type 2 diabetes (T2D), suggests a recent study.

Hypothyroidism, lower FT4 levels tied to greater T2D risk
24 May 2022